Tudor Toma(t.toma@ic.ac.uk) | Sep 13, 2001 | 1 min read
The characteristic pain crises and organ failure seen in sickle cell disease results from the abnormal red blood cells adhesion to the endothelium of small vessels and subsequent blood flow cessation. In September 15 Blood, Neil Matsui and colleagues from University of California at San Francisco describe a new cell adhesion mechanism involving the P-selectin molecule that could lead to improved treatments for sickle cell disease.P-selectin is an adhesion protein present on activated endothelial